Literature DB >> 3100641

Species-specific variations in the molecular heterogeneity of the platelet-activating factor.

C S Ramesha, W C Pickett.   

Abstract

The molecular heterogeneity of platelet-activating factor (PAF) synthesized by unstimulated and Ca2+ ionophore (A23187)-stimulated PMN from rat, mouse, and guinea pig and by rat basophilic leukemia (RBL) cells was investigated by gas chromatography-negative ion chemical ionization mass spectrometry. Several molecular species of PAF ranging from C14:0 to C19:0 were detected in all of the cells studied. PAF produced by each cell type exhibited a unique pattern of molecular species distribution. Although C16:0 was the major PAF molecular species of rat PMN and RBL cells representing 96% and 85% of the total PAF, respectively, PAF from mice PMN contained 81% of C16:0, 10% of C18:1, and 6% of C18:0. Alternatively, A23187-stimulated guinea pig PMN yielded PAF molecular species 35% in C16:0, 35% in C17:0, 8% in C18:1, and 3% in C18:0. Small but significant differences in the PAF molecular species distribution of resting and ionophore stimulated cells were also observed. In contrast to the PAF molecular species composition, the precursor 1-O-alkyl-2-acyl-glycero-3-phosphocholine of all the cell types was predominantly hexadecyl (C16:0) alkyl chain in the sn-1 position, representing 60 to 80% of the total 1-O-alkyl-2-acyl-glycero-3-phosphocholine. Thus, these results not only indicate a high degree of selectivity for utilization of precursor substrates for PAF biosynthesis, but also demonstrate that the selectivity is species specific.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3100641

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  7 in total

1.  Determination of platelet-activating factor by a chemiluminescence method and its application to stimulated guinea pig neutrophils.

Authors:  Y Hasegawa; E Kunow; J Shindou; H Yuki
Journal:  Lipids       Date:  1991-12       Impact factor: 1.880

2.  Eosinophil migration in response to three molecular species of platelet activating factor.

Authors:  R A Erger; T B Casale
Journal:  Inflamm Res       Date:  1996-06       Impact factor: 4.575

Review 3.  Structural and (patho)physiological diversity of PAF.

Authors:  R N Pinckard; D S Woodard; H J Showell; M J Conklyn; M J Novak; L M McManus
Journal:  Clin Rev Allergy       Date:  1994

4.  Effect of platelet activating factor (PAF) on the migration of human lymphocytes.

Authors:  R G McFadden; M A Bishop; A N Caveney; L J Fraher
Journal:  Thorax       Date:  1995-03       Impact factor: 9.139

5.  Expression of human platelet-activating factor receptor gene in EoL-1 cells following butyrate-induced differentiation.

Authors:  T Izumi; S Kishimoto; T Takano; M Nakamura; Y Miyabe; M Nakata; C Sakanaka; T Shimizu
Journal:  Biochem J       Date:  1995-02-01       Impact factor: 3.857

6.  Characterization of platelet-activating factor synthesized by normal and granulocyte-macrophage colony-stimulating factor-primed human eosinophils.

Authors:  M Triggiani; R P Schleimer; K Tomioka; W C Hubbard; F H Chilton
Journal:  Immunology       Date:  1992-12       Impact factor: 7.397

7.  Molecular heterogeneity of platelet-activating factor (PAF) in rat glandular stomach determined by gas chromatography/mass spectrometry. PAF molecular species changes upon water-immersion stress.

Authors:  J Sugatani; K Fujimura; M Miwa; K Satouchi; K Saito
Journal:  Lipids       Date:  1991-12       Impact factor: 1.880

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.